Rowlands Pharmacy acquires 30 LloydsPharmacy branches in Scotland


Share post:

Rowlands Pharmacy has announced that it has acquired 30 LloydsPharmacy branches in Scotland.

The community pharmacy group owned by the wider Numark network now has over 70 directly owned branches in Scotland.

Nigel Swift, managing director of Rowlands Pharmacy, said: “This is a significant investment in growing our network north of the border and further reinforces our presence in Scotland delivering outstanding patient care services, advice and support. We welcome our new colleagues into the Numark family.”

For many years, the Scottish government has supported community pharmacy at the forefront of providing NHS care which people want, need and value with a commitment that has delivered for patients and the NHS, he said.

“We are investing in Scotland in the expectation that support from the Scottish government will continue in the years ahead to recognise the critical role of community pharmacy at the beating heart of healthcare provision from illness prevention through to long-term condition management,” Swift added.


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...